First Time Loading...

Dr Martens PLC
LSE:DOCS

Watchlist Manager
Dr Martens PLC Logo
Dr Martens PLC
LSE:DOCS
Watchlist
Price: 72.65 GBX 1.82%
Updated: Apr 26, 2024

Intrinsic Value

Dr. Martens Plc engages in the manufacture and sale of footwear products. [ Read More ]

The intrinsic value of one DOCS stock under the Base Case scenario is 183.87 GBX. Compared to the current market price of 72.65 GBX, Dr Martens PLC is Undervalued by 60%.

Key Points:
DOCS Intrinsic Value
Base Case
183.87 GBX
Undervaluation 60%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Dr Martens PLC

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling DOCS stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Dr Martens PLC

Provide an overview of the primary business activities
of Dr Martens PLC.

What unique competitive advantages
does Dr Martens PLC hold over its rivals?

What risks and challenges
does Dr Martens PLC face in the near future?

Summarize the latest earnings call
of Dr Martens PLC.

What significant events have occurred
in Dr Martens PLC over the past months?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Dr Martens PLC.

Provide P/S
for Dr Martens PLC.

Provide P/E
for Dr Martens PLC.

Provide P/OCF
for Dr Martens PLC.

Provide P/FCFE
for Dr Martens PLC.

Provide P/B
for Dr Martens PLC.

Provide EV/S
for Dr Martens PLC.

Provide EV/GP
for Dr Martens PLC.

Provide EV/EBITDA
for Dr Martens PLC.

Provide EV/EBIT
for Dr Martens PLC.

Provide EV/OCF
for Dr Martens PLC.

Provide EV/FCFF
for Dr Martens PLC.

Provide EV/IC
for Dr Martens PLC.

Show me price targets
for Dr Martens PLC made by professional analysts.

What are the Revenue projections
for Dr Martens PLC?

How accurate were the past Revenue estimates
for Dr Martens PLC?

What are the Net Income projections
for Dr Martens PLC?

How accurate were the past Net Income estimates
for Dr Martens PLC?

What are the EPS projections
for Dr Martens PLC?

How accurate were the past EPS estimates
for Dr Martens PLC?

What are the EBIT projections
for Dr Martens PLC?

How accurate were the past EBIT estimates
for Dr Martens PLC?

Compare the revenue forecasts
for Dr Martens PLC with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Dr Martens PLC and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Dr Martens PLC against its competitors.

Analyze the profit margins
(gross, operating, and net) of Dr Martens PLC compared to its peers.

Compare the P/E ratios
of Dr Martens PLC against its peers.

Discuss the investment returns and shareholder value creation
comparing Dr Martens PLC with its peers.

Analyze the financial leverage
of Dr Martens PLC compared to its main competitors.

Show all profitability ratios
for Dr Martens PLC.

Provide ROE
for Dr Martens PLC.

Provide ROA
for Dr Martens PLC.

Provide ROIC
for Dr Martens PLC.

Provide ROCE
for Dr Martens PLC.

Provide Gross Margin
for Dr Martens PLC.

Provide Operating Margin
for Dr Martens PLC.

Provide Net Margin
for Dr Martens PLC.

Provide FCF Margin
for Dr Martens PLC.

Show all solvency ratios
for Dr Martens PLC.

Provide D/E Ratio
for Dr Martens PLC.

Provide D/A Ratio
for Dr Martens PLC.

Provide Interest Coverage Ratio
for Dr Martens PLC.

Provide Altman Z-Score Ratio
for Dr Martens PLC.

Provide Quick Ratio
for Dr Martens PLC.

Provide Current Ratio
for Dr Martens PLC.

Provide Cash Ratio
for Dr Martens PLC.

What is the historical Revenue growth
over the last 5 years for Dr Martens PLC?

What is the historical Net Income growth
over the last 5 years for Dr Martens PLC?

What is the current Free Cash Flow
of Dr Martens PLC?

Discuss the annual earnings per share (EPS)
trend over the past five years for Dr Martens PLC.

Financials

Balance Sheet Decomposition
Dr Martens PLC

Current Assets 491.5m
Cash & Short-Term Investments 45.7m
Receivables 130.3m
Other Current Assets 315.5m
Non-Current Assets 536.9m
Long-Term Investments 1m
PP&E 259.4m
Intangibles 265.5m
Other Non-Current Assets 11m
Current Liabilities 201.4m
Accounts Payable 124.8m
Other Current Liabilities 76.6m
Non-Current Liabilities 463.4m
Long-Term Debt 456.7m
Other Non-Current Liabilities 6.7m
Efficiency

Earnings Waterfall
Dr Martens PLC

Revenue
977.5m GBP
Cost of Revenue
-362.3m GBP
Gross Profit
615.2m GBP
Operating Expenses
-454.1m GBP
Operating Income
161.1m GBP
Other Expenses
-57.9m GBP
Net Income
103.2m GBP

Free Cash Flow Analysis
Dr Martens PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

DOCS Profitability Score
Profitability Due Diligence

Dr Martens PLC's profitability score is 67/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Positive Gross Profit
Positive 3-Year Average ROIC
Positive Free Cash Flow
67/100
Profitability
Score

Dr Martens PLC's profitability score is 67/100. The higher the profitability score, the more profitable the company is.

DOCS Solvency Score
Solvency Due Diligence

Dr Martens PLC's solvency score is 49/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Average D/E
49/100
Solvency
Score

Dr Martens PLC's solvency score is 49/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

DOCS Price Targets Summary
Dr Martens PLC

Wall Street analysts forecast DOCS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DOCS is 97.69 GBX with a low forecast of 85.85 GBX and a high forecast of 115.5 GBX.

Lowest
Price Target
85.85 GBX
18% Upside
Average
Price Target
97.69 GBX
34% Upside
Highest
Price Target
115.5 GBX
59% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

DOCS Price
Dr Martens PLC

1M 1M
-15%
6M 6M
-37%
1Y 1Y
-56%
3Y 3Y
-84%
5Y 5Y
-83%
10Y 10Y
-83%
Annual Price Range
72.65
52w Low
67
52w High
171.2
Price Metrics
Average Annual Return -29%
Standard Deviation of Annual Returns 34.66%
Max Drawdown -87%
Shares Statistics
Market Capitalization 705.3m GBX
Shares Outstanding 1 002 000 000
Percentage of Shares Shorted 151%

DOCS Return Decomposition
Main factors of price return

What is price return decomposition?

DOCS News

Last Important Events
Dr Martens PLC

Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.

All
Positive
Negative

Sentiment Analysis
Dr Martens PLC

Today
Last 7 Days 7D
Last 30 Days 30D
Last 90 Days 90D

Company Profile

Dr Martens PLC Logo
Dr Martens PLC

Country

United Kingdom

Industry

Textiles, Apparel & Luxury Goods

Market Cap

705.3m GBP

Dividend Yield

7.88%

Description

Dr. Martens Plc engages in the manufacture and sale of footwear products. The firm operates through three reporting segments: Europe, the Middle East and Africa (EMEA), Americas and Americas and Asia-Pacific (APAC). Its product categories include Originals, Fusion, Kids, Casual and Accessories. The Originals category comprises boots, shoes and loafers and also included within the Originals category is the Made in England range. The Fusion category comprises platform boots and shoes, sandals, heels and refined take downs of the Originals. Within the Kids category is the mini-me range, which includes Originals, Fusion and Casual collections. The company offers various accessories, such as shoe care, laces and socks, leather bags and small leather items. The company operates in over 60 countries globally, through a range of modes: directly operated stores and ecommerce sites, wholesale partners and distributors.

Contact

London
28 Jamestown Rd, Camden
+443713842030.0
https://www.drmartensplc.com/

IPO

2021-01-29

Employees

1 897

Officers

CEO & Director
Mr. Kenneth Wilson
CFO & Director
Mr. Jon William Mortimore
Chief Brand Officer
Mr. Onyeije Ogueri Nwokorie
Chief Operating Officer
Mr. Geert Peeters
Chief Information Officer
Mr. Ronald Garricks
Chief Marketing Officer
Ms. Meg Johnson
Show More
Chief People & Sustainability Officer and Company Secretary
Ms. Emily Clare Reichwald
Chief Digital Officer
Mr. Sean O'Neill
President of APAC
Mr. Derek Chan
Chief Product Officer
Mr. Adam M. Meek
Show Less

See Also

Discover More
What is the Intrinsic Value of one DOCS stock?

The intrinsic value of one DOCS stock under the Base Case scenario is 183.87 GBX.

Is DOCS stock undervalued or overvalued?

Compared to the current market price of 72.65 GBX, Dr Martens PLC is Undervalued by 60%.